Literature DB >> 23474685

Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Cecilia Johansson1, Stefan Schwartz.   

Abstract

Human papillomaviruses (HPVs) are small DNA tumour viruses that are present in more than 99% of all cervical cancers. The ability of these viruses to cause disease is partly attributed to the strict coordination of viral gene expression with the differentiation stage of the infected cell. HPV gene expression is regulated temporally at the level of RNA splicing and polyadenylation, and a dysregulated gene expression programme allows some HPV types to establish long-term persistence, which is a risk factor for cancer. In this Review, we summarize the role of splicing and polyadenylation in the regulation of HPV gene expression and discuss the viral and cellular factors that control these processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474685     DOI: 10.1038/nrmicro2984

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  139 in total

Review 1.  Initiation of DNA replication: lessons from viral initiator proteins.

Authors:  Arne Stenlund
Journal:  Nat Rev Mol Cell Biol       Date:  2003-10       Impact factor: 94.444

2.  Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.

Authors:  J Doorbar; S Ely; J Sterling; C McLean; L Crawford
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

3.  Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA.

Authors:  A Kanopka; O Mühlemann; G Akusjärvi
Journal:  Nature       Date:  1996-06-06       Impact factor: 49.962

4.  A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

Authors:  Daniel Oberg; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification.

Authors:  Kathryn M Spink; Laimonis A Laimins
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Translational properties of the human papillomavirus type-6 L1-coding mRNA.

Authors:  Y Tomita; B Simizu
Journal:  Gene       Date:  1993-11-15       Impact factor: 3.688

7.  Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.

Authors:  C Leder; J A Kleinschmidt; C Wiethe; M Müller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Codon optimization of the HPV-16 E5 gene enhances protein expression.

Authors:  Gary L Disbrow; Iruvanti Sunitha; Carl C Baker; John Hanover; Richard Schlegel
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

9.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 10.  Human papillomavirus immortalization and transformation functions.

Authors:  Karl Münger; Peter M Howley
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

View more
  64 in total

1.  Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.

Authors:  Soniya Dhanjal; Naoko Kajitani; Jacob Glahder; Ann-Kristin Mossberg; Cecilia Johansson; Stefan Schwartz
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 2.  Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.

Authors:  Vinayak Vittal; Mikaela D Stewart; Peter S Brzovic; Rachel E Klevit
Journal:  J Biol Chem       Date:  2015-07-17       Impact factor: 5.157

3.  HeLa nucleic acid contamination in the cancer genome atlas leads to the misidentification of human papillomavirus 18.

Authors:  Paul G Cantalupo; Joshua P Katz; James M Pipas
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

Review 5.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  ViFi: accurate detection of viral integration and mRNA fusion reveals indiscriminate and unregulated transcription in proximal genomic regions in cervical cancer.

Authors:  Nam-Phuong D Nguyen; Viraj Deshpande; Jens Luebeck; Paul S Mischel; Vineet Bafna
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

7.  Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa.

Authors:  Els van der Meijden; Siamaque Kazem; Christina A Dargel; Nick van Vuren; Paul J Hensbergen; Mariet C W Feltkamp
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

Review 8.  Modulation of the DNA damage response during the life cycle of human papillomaviruses.

Authors:  Daniel C Anacker; Cary A Moody
Journal:  Virus Res       Date:  2016-11-09       Impact factor: 3.303

9.  Minute Virus of Canines NP1 Protein Interacts with the Cellular Factor CPSF6 To Regulate Viral Alternative RNA Processing.

Authors:  Yanming Dong; Olufemi O Fasina; David J Pintel
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  NP1 Protein of the Bocaparvovirus Minute Virus of Canines Controls Access to the Viral Capsid Genes via Its Role in RNA Processing.

Authors:  Olufemi O Fasina; Yanming Dong; David J Pintel
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.